Patients with EGFR Mutant (m) MET-altered NSCLC Receiving Tepotinib with an EGFR Tyrosine Kinase Inhibitor (TKI): A Case Series.
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
EGFR Mutations,EGFR Inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined